Investor data available

Who we are

Biohit Oyj is a biotechnology company with global operations. Established in 1988, Biohit’s mission is ‘Innovating for Health’ – we provide innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki under the Small cap/Healthcare group.

Our solution

Biohit develops and manufactures safe and cost-effective diagnostic tests and other products for the early detection and prevention of diseases of the gastrointestinal tract. Many of Biohit´s products are unique and patented and have been developed through decades of scientific research.

Biohit´s diagnostic test line include the blood sample-based GastroPanel® examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding – an indicator of risk of colorectal cancer.

One of our recent innovations is Acetium. The Acetium capsule reduces carcinogenic acetaldehyde in the gastrointestinal tract and is meant for those who, for some reason or another, have an anacidic or low acid stomach. The Acetium lozenge reduces carcinogenic acetaldehyde from saliva during smoking. Additionally Acetium is currently used in clinical studies investigating its effect in smoking cessation and migraine prevention.

Biohit's operations are based on a goal-oriented, long-term innovation and patenting strategy.

benefits

Our goal is to improve people’s quality of life by preventing diseases and to contribute to savings in healthcare costs.  Gastrointestinal diseases are growing worldwide phenomenon, with related medical, ethical and financial problems. As the population ages, the need for healthcare will increase further, leading to an urgent requirement for new, cost-effective solutions. Biohit continuously develops its products and services to address growing needs.

What we are looking for

We are looking for distribution partners specialising in gastrointestinal disorders worldwide. Our patented, safe and unique Acetium products, patient-friendly GastoPanel® blood test and BIOHIT quick tests offer a purpose-built range for potential partners involved in gastrointestinal diagnosis and stomach health.

Team profiles

President & CEO Semi Korpela
M.Sc. (Econ.)
https://twitter.com/Semi_seCo

Contact information

Biohit Oyj Headquarters

info(a)biohit.fi

Tel: +358 9 773 861

www.biohithealthcare.com/

Fax: +358 9 773 2867

Laippatie 1, 00880 Helsinki, FINLAND


Related posts